An interventional study of Instrument Assisted Soft Tissue Mobilization (IASTM) and dry cupping in Chronic Myofascial Low Back Pain, sponsored by Ibadat International University, Islamabad. Recruiting at 1 site in Pakistan. Open to participants aged 25 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-07-06.
Sponsored by Ibadat International University, Islamabad · Not applicable, Interventional, and Treatment
This study aims to compare the effects of Dry Dynamic Cupping and Instrument-Assisted Soft Tissue Mobilization (IASTM) in patients with chronic myofascial low back pain. The interventions will be evaluated for their effectiveness in reducing pain, improving functional disability, and enhancing quality of life. The findings may help identify a more effective treatment approach for managing chronic myofascial low back pain.
376 studies on the registry are indexed under Bronchiolitis Obliterans Syndrome; 104 are open to participants now.
This study's planned enrollment of 48 is above the median of 35 across 296 interventional studies indexed under Bronchiolitis Obliterans Syndrome.
Browse Bronchiolitis Obliterans Syndrome studies →Ibadat International University, Islamabad is the lead sponsor of 49 studies on the registry; 32 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants in this group will receive Dry Dynamic Cupping therapy. The intervention will be administered for 2 weeks, with 3 treatment sessions per week, according to the standardized study protocol. The effects of the intervention will be evaluated on pain intensity, functional disability, and lumbar range of motion.
Other: Instrument Assisted Soft Tissue Mobilization (IASTM) · Other: dry cupping
Participants in this group will receive Instrument-Assisted Soft Tissue Mobilization (IASTM). The intervention will be administered for 2 weeks, with 3 treatment sessions per week, according to the standardized study protocol. The effects of the intervention will be evaluated on pain intensity, functional disability, and lumbar range of motion.
Other: Instrument Assisted Soft Tissue Mobilization (IASTM) · Other: dry cupping
Participants in this group will receive Instrument-Assisted Soft Tissue Mobilization (IASTM). The intervention will be administered for 2 weeks, with 3 treatment sessions per week, according to the standardized study protocol. The effects of the intervention will be evaluated on pain intensity, functional disability, and lumbar range of motion.
Participants in this group will receive Dry Dynamic Cupping therapy. The intervention will be administered for 2 weeks, with 3 treatment sessions per week, according to the standardized study protocol. The effects of the intervention will be evaluated on pain intensity, functional disability, and lumbar range of motion.
NPRS
Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), an 11-point scale ranging from 0 (no pain) to 10 (worst imaginable pain). Changes in pain scores will be compared between the Dry Dynamic Cupping and IASTM groups.
Time frame: Baseline and 2 Weeks Post-Intervention
ODI
Functional disability related to low back pain will be assessed using the Oswestry Disability Index (ODI). Changes in disability scores will be compared between groups.
Time frame: Baseline and 2 Weeks Post-Intervention
Inclinometer
Lumbar range of motion (ROM) will be measured using an inclinometer. Flexion, extension, right and left side flexion, and right and left rotation will be assessed to evaluate changes in lumbar mobility following the intervention and compared between the Dry Dynamic Cupping and IASTM groups.
Time frame: Baseline and 2 Weeks Post-Intervention
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bronchiolitis Obliterans Syndrome→
Ibadat International University, Islamabad